Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine.
Costagliola
D
D
Mary-Krause
M
M
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D015982:Bias; D005260:Female; D005500:Follow-Up Studies; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D006679:HIV Seropositivity; D006801:Humans; D007256:Information Systems; D008297:Male; D016016:Proportional Hazards Models; D012307:Risk Factors; D012514:Sarcoma, Kaposi / Q000517:prevention & control*
D000998:Antiviral Agents; D017245:Foscarnet; D015774:Ganciclovir; D000212:Acyclovir